Participate in a Migraine Research Study
If you or someone you love suffers from migraines, perhaps you should consider participating in a clinical research study. Perhaps the best reason to participate in a clinical trial is so that you can take an active role in your health care, by educating yourself regarding your condition. You will obtain access to top quality medical care from our Board Certified physicians at a medical research healthcare facility specializing in migraines.
Health insurance is not necessary to participate. Patients who qualify for our clinical trials will receive all study related care and treatment at no cost. In some cases you may be compensated for your time and travel. You may even gain access to research treatments before they are widely available.
Interested in learning about our migraine research studies going on at Premiere Research Institute? Contact us by calling (561) 845-0500 or fill out the form below.
The ultimate goal of migraine research is the relief of all migraine episodes. Today it is possible for this to be accomplished in a small percentage of people and ultimately we hope to vastly improve the percentage over the next several years.
Today we do have new treatments primarily because we have a greater understanding of how a migraine is caused. Some of our latest research focuses on controlling the neuropeptide called calcitonin gene related peptide [CGRP]. If we can block this neurotransmitter from working we can significantly influence the potential for a migraine to develop. Today we are studying compounds that can block CGRP at the molecular level.
Premiere Research Institute is currently seeking volunteers for the H8H-MC-LAHX Study.
What is the H8H-MC-LAHX study?
This study is being conducted to determine the dose of an investigational study drug to be given to participants in future studies of children and teens with migraines.
Who can take part?
We are looking for children and teens 6 to <18 years of age with a history of migraines to take part in this clinical research study. Learn more here.
Articles about Migraines
To read one of our most recent articles about Migraines just click the title of the article.
A novel treatment option for acute migraine that is currently under review by the Food and Drug Administration (FDA) has shown promising results in the reduction of pain and disability in acute migraine sufferers. The drug ubrogepant, developed by Allergen, is a small...read more
Over the past decade, there has been a significant amount of progress made in the development of new preventative migraine therapies that differ from previous treatment types. One such breakthrough was the recent FDA approval of medications in a novel class of drugs...read more
Most people who experience migraine headaches have a number of triggers which can kick-start an acute episode. By understanding what these triggers are, migraine sufferers can make lifestyle adjustments that can help to prevent or minimize the frequency and severity...read more
A new and unique class of preventive migraine treatments have been approved by the FDA over the past year which have several benefits over older medications for the prevention of migraine. Anti-CGRP medicines, which are monoclonal antibodies, block the activity of...read more
Today there are more treatment options available for people who suffer from migraine than ever before. As a result, people with migraine are now better able to manage their symptoms due to the variety of therapies available, whether through drug or non-drug...read more
Migraine and tension headaches are often painful, but there are notable differences between them that many people are unaware of. It is important to know what these differences are, as they can be pivotal in deciding to seek out a proper diagnosis and treatment. While...read more
A new small molecule calcitonin gene-related peptide (CGRP) drug in phase 3 clinical trials has shown promising relief of migraine symptoms when administered as an acute single-dose treatment. The migraine drug, Rimegepant, relieved pain and other bothersome migraine...read more
A large global survey of migraine patients which included over 11,000 respondents from 31 countries found that many migraine sufferers commonly deal with functional impairments at work due to their symptoms. Respondents of the survey had at least four migraine days...read more
Adults with migraine now have an additional preventative treatment option available to them, thanks to a new and unique migraine medication that has been approved by the Food and Drug Administration (FDA). Aimovig (erenumab-aooe) is a novel, first of its kind...read more
Today, there are a variety of different migraine prevention options which can help ease the lifestyle burdens that migraine sufferers often live with. There are several goals to migraine prevention, such as a lessening of functional impairments and disability,...read more